ESR1 and breast carcinoma: Recent studies of endocrine resistance and breast cancer plasticity have confirmed specific functions of the CoREST complex in mediating resistance to endocrine therapies in estrogen receptor–positive (ER+) breast cancers and associated tumor cell plasticity (17).